Opioid-Related Disorders

"Opioid-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders related or resulting from abuse or mis-use of opioids.

Descriptor ID	D009293
MeSH Number(s)	C25.775.675 F03.900.675
Concept/Terms	Opioid-Related Disorders Opioid-Related Disorders Disorder, Opioid-Related Opioid Abuse Abuse, Opioid Abuses, Opioid Opioid Abuses Opiate Abuse Abuse, Opiate Abuses, Opiate Opiate Abuses Opiate Dependence Opiate Dependence Dependence, Opiate Opiate Addiction Addiction, Opiate

Below are MeSH descriptors whose meaning is more general than "Opioid-Related Disorders".

Diseases [C]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Opioid-Related Disorders [C25.775.675]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Substance-Related Disorders [F03.900]
Opioid-Related Disorders [F03.900.675]

Below are MeSH descriptors whose meaning is related to "Opioid-Related Disorders".

Below are MeSH descriptors whose meaning is more specific than "Opioid-Related Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Opioid-Related Disorders" by people in this website by year, and whether "Opioid-Related Disorders" was a major or minor topic of these publications.

Bar chart showing 333 publications over 25 distinct years, with a maximum of 40 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	0	2
1997	1	1	2
2000	1	0	1
2002	1	0	1
2005	2	0	2
2006	1	1	2
2007	3	0	3
2008	4	2	6
2009	3	0	3
2010	4	1	5
2011	4	0	4
2012	6	0	6
2013	4	1	5
2014	12	1	13
2015	8	0	8
2016	16	4	20
2017	20	2	22
2018	22	2	24
2019	21	7	28
2020	30	2	32
2021	27	1	28
2022	35	0	35
2023	35	0	35
2024	32	8	40
2025	6	0	6

Below are the most recent publications written about "Opioid-Related Disorders" by people in Profiles.

Oliveto AH, McGaugh J, Chopra MP, Thostenson J, Mancino MJ. A randomized clinical trial of disulfiram at higher doses for the treatment of cocaine use disorder among methadone-stabilized patients. J Psychiatr Res. 2025 Jun; 186:387-395.

View in: PubMed
Morenz AM, Nance RM, Mixson LS, Feinberg J, Smith G, Korthuis PT, Pho MT, Jenkins WD, Friedmann PD, Stopka TJ, Fanucchi LC, Miller WC, Go VF, Westergaard R, Seal DW, Zule WA, Crane HM, Delaney JA, Tsui JI. Barriers to accessing medications for opioid use disorder among rural individuals. Int J Drug Policy. 2025 Jun; 140:104805.

View in: PubMed
Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA. Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails. JAMA Netw Open. 2025 Apr 01; 8(4):e255340.

View in: PubMed
Williams BE, Martin SA, Hoffman KA, Andrus MD, Dellabough-Gormley E, Buchheit BM. "It's within your own power": shared decision-making to support transitions to buprenorphine. Addict Sci Clin Pract. 2025 Mar 07; 20(1):22.

View in: PubMed
Bayly R, Cordes J, Bernson D, Ackerson LK, LaRochelle MR, Hassan GH, Bauer CX, Stopka TJ. Predicting fatal opioid-involved overdoses: A social-ecological framework matched to a linked-data warehouse. Int J Drug Policy. 2025 Mar; 137:104730.

View in: PubMed
Lynn T, Kelleher ME, Georges HM, McCauley EM, Logan RW, Yonkers KA, Abrahams VM. Buprenorphine induces human fetal membrane sterile inflammation. J Reprod Immunol. 2025 Mar; 168:104445.

View in: PubMed
Goodman GR, Overstreet DS, Wilson JM, O'Cleirigh C, Boyer EW, Meints SM, Taylor SW, Mayer KH, Schreiber KL, Chai PR. Acceptability of a Smartphone-Based Music Intervention for Chronic Pain and Problematic Opioid Use Among People with HIV: A Mixed-Methods Pilot Study. AIDS Res Hum Retroviruses. 2025 May; 41(5):263-273.

View in: PubMed
Kang AW, Bailey A, Surace A, Stein L, Rohsenow D, Martin RA. Medications for opioid use disorders among incarcerated persons and those in the community supervision setting: exploration of implementation issues with key stakeholders. Addict Sci Clin Pract. 2024 Dec 18; 19(1):95.

View in: PubMed
Pivovarova E, Planas Garcia BY, Friedmann PD, Stopka TJ, Santelices C, Evans EA. Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers. J Addict Med. 2025 Jan-Feb 01; 19(1):95-101.

View in: PubMed
Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K, Tsui JI, Young AM, Cooper H, Korthuis PT, Pho MT, Jenkins W, Westergaard RP, Go VF, Brook D, Smith G, Rice DR, Lancaster KE. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.

View in: PubMed

People

Explore

Similar Concepts

Top Journals